A globally skilled, well-resourced Research and Service Company from Italy conducts serological tests to evaluate the immunogenicity of vaccines, creates and validates bioanalytical methods and experimental protocols for the release of therapeutic molecules.

A globally skilled, well-resourced Research and Service Company that supports vaccine and pharma industries in improving public health through the development and optimization of safer and more effective vaccines and drugs.

Thanks to the profound scientific expertise and experience of its management and staff, this company conducts serological tests to evaluate the immunogenicity of vaccines, creates and validates bioanalytical methods and experimental protocols for the release of therapeutic molecules.

The logic driving this company’s collaboration with key customers is based on creating a long-term partnership based on continuity, trust and stability relationships embodied in the sharing of objectives and instruments to identify professional winning solutions.

All the implemented activities are very high quality and internally validated in order to ensure maximum customization upon customer request. This company is thus capable of offering an accurate analytical result.

The tests carried out by This company always require a validation process consistent with international guidelines such as “Validation of Analytical Procedures: Text and Methodology (ICH)” and as required by leading international regulatory bodies such as EMA (European Medicines Agency), FDA (Food and Drug Administration) and PMDA (Pharmaceuticals and Medical Devices Agency).

This company offers its clients a large portfolio of qualified biochemical assays including preclinical and clinical activities.

The tests carried out within this company’s facilities constantly undergo validation and standardization procedures in order to ensure high-quality protocols applicable both in clinical trial settings and in research contexts.

All laboratory tests are performed in BSL2, BSL3 and BSL3+ containment facilities. This company’s Assays Development Division deals with the creation, optimization and standardization of bioanalytical microbiological, serological and virological assays and tests associated with vaccines immunogenicity assessment and epidemiological screening.

Looking for vaccine and pharmaceutical company who need laboratory support in preclinical and clinical phases. Research centers with activities in the area of vaccines and infectious diseases.

Erika HAN

Tel: 086-028-85335757

Email: Erika_han@eupic.cn